Clinical Trial Update: Autologous Stem Cell Transplant in Treating Patients With Progressive or Recurrent Hodgkin's Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating autologous stem cell transplant in patients with progressive or recurrent Hodgkin lymphoma, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hodgkin Lymphoma

Snippet

Sponsor: Case Comprehensive Cancer Center | Conditions: Lymphoma | Phase 2 | Status: COMPLETED | Results posted: 2013-08-26